Related Experiment Videos
[Dyslipoproteinemia in elderly patients]
V Bláha1, D Solichová, Z Zadák
1Klinika gerontologická a metabolická Fakultní nemocnice UK, Hradec Králové.
Vnitrni Lekarstvi
|May 10, 2001
Summary
Dyslipoproteinaemia remains a key risk factor for cardiovascular disease in the elderly, with lipid levels still predictive. Treatment strategies emphasize individualized approaches, diet, exercise, and pharmacotherapy for high-risk individuals.
Area of Science:
- Cardiology
- Geriatrics
- Metabolic Disorders
Context:
- Dyslipoproteinaemia is a significant risk factor for atherosclerotic cardiovascular diseases (ASCVD).
- The predictive value of lipid profiles (total cholesterol, LDL-C, HDL-C, triglycerides, lipoprotein(a)) is maintained in the elderly population.
- Post-hoc analyses of major clinical studies provide data on managing dyslipoproteinaemia in older adults.
Purpose:
- To review the role of dyslipoproteinaemia in ASCVD among the elderly.
- To discuss current treatment guidelines and strategies for dyslipoproteinaemia in older individuals.
- To highlight the importance of individualized treatment approaches.
Summary:
- Lipid levels remain predictive of cardiovascular risk in the aged.
- Treatment decisions for dyslipoproteinaemia in the elderly are guided by individual risk factors and clinical guidelines, often continuing treatment for genetic forms.
- Patients with coronary heart disease (CHD) or subclinical CHD benefit significantly from lipid-lowering interventions, with up to a 45% reduction in CHD risk.
- Diet and exercise are foundational, while pharmacotherapy (statins, fibrates) is reserved for high-risk patients, initiated at lower doses with careful monitoring for adverse effects.
Impact:
- Informs clinical practice regarding the management of dyslipoproteinaemia in elderly patients.
- Emphasizes a personalized approach to cardiovascular risk reduction in older adults.
- Highlights the continued relevance of lipid management in preventing ASCVD events in the aging population.